`

iCardiac

Biotechnology Research

Specialities :
Cardiac safety services
Respiratory services
Phase i qt assessment
Tqt studies
Phase ii-iv cardiac safety

+5

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About iCardiac

What does Icardiac do?+

iCardiac Technologies was acquired by ERT in December, 2017. ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, we balance knowledge of what works with a vision for whats next, so we can adapt without compromising standards. Powered by the companys EXPERT technology platform, our solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half...

What are Icardiac's specialties? +

Cardiac safety services,respiratory services,phase i qt assessment,tqt studies,phase ii-iv cardiac safety,spirometry,consulting,electronic clinical outcome assessments (ecoa),centralized trial oversight,and advanced imaging

What is Icardiac's industry? +

Icardiac operates in the Biotechnology research industry.

What is Icardiac's revenue? +

Icardiac's revenue is 11m - 100m

What is Icardiac's company size? +

Icardiac has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.